Published in J Virol on March 04, 2009
Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe (2010) 1.70
Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection. J Virol (2012) 1.14
Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. PLoS Pathog (2010) 1.14
Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo. PLoS One (2012) 1.05
Histone deacetylases and the nuclear receptor corepressor regulate lytic-latent switch gene 50 in murine gammaherpesvirus 68-infected macrophages. J Virol (2010) 0.95
Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection. J Virol (2012) 0.95
Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection. PLoS One (2010) 0.93
Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection. J Virol (2010) 0.92
Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis. Am J Pathol (2010) 0.88
The Role of Gammaherpesviruses in Cancer Pathogenesis. Pathogens (2016) 0.83
Characterization of omental immune aggregates during establishment of a latent gammaherpesvirus infection. PLoS One (2012) 0.81
Infection-Induced Retrotransposon-Derived Noncoding RNAs Enhance Herpesviral Gene Expression via the NF-κB Pathway. PLoS Pathog (2015) 0.80
The absence of M1 leads to increased establishment of murine gammaherpesvirus 68 latency in IgD-negative B cells. J Virol (2013) 0.80
Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA. J Virol (2014) 0.80
Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host. Front Microbiol (2016) 0.78
Murine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture. J Virol (2015) 0.77
Ablation of STAT3 in the B Cell Compartment Restricts Gammaherpesvirus Latency In Vivo. MBio (2016) 0.75
RTA Occupancy of the Origin of Lytic Replication during Murine Gammaherpesvirus 68 Reactivation from B Cell Latency. Pathogens (2017) 0.75
Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell (1995) 7.55
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med (1996) 6.08
The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell (2002) 5.84
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol (2002) 5.09
Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature (1997) 4.12
Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol (1999) 4.12
Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol (1996) 4.02
Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med (1998) 3.45
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell (2003) 3.42
Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med (1997) 3.40
CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J (2002) 3.30
Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest (2001) 3.28
Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J (2004) 3.01
Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. J Immunol (2006) 2.96
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med (1998) 2.80
B cells regulate murine gammaherpesvirus 68 latency. J Virol (1999) 2.79
Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science (1999) 2.61
Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood (2000) 2.53
B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol (1996) 2.53
Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci (2001) 2.50
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci U S A (2000) 2.48
KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med (2004) 2.39
Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med (2002) 2.20
Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J Virol (1996) 2.19
NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol (2003) 2.15
BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol (2006) 2.09
NF-kappaB and virus infection: who controls whom. EMBO J (2003) 2.08
Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J Immunol (2007) 2.07
Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol (2003) 2.01
B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med (1998) 2.00
Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol (1995) 1.91
Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol (2007) 1.74
Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol (2003) 1.64
Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J Immunol (2006) 1.62
Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol (1996) 1.61
The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc Natl Acad Sci U S A (2002) 1.59
NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood (2005) 1.56
Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol (2002) 1.48
Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. J Virol (2005) 1.46
Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc Natl Acad Sci U S A (2005) 1.41
Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness. Am J Respir Crit Care Med (2008) 1.40
Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog (2007) 1.39
Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol (2006) 1.39
Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice. Cell Death Differ (2006) 1.36
The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol (2005) 1.35
Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J Virol (2005) 1.35
Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res (2007) 1.33
The human major histocompatibility complex class II HLA-DRB1 and HLA-DQA1 genes are separated by a CTCF-binding enhancer-blocking element. J Biol Chem (2006) 1.32
A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. J Exp Med (2008) 1.31
Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways. Oncogene (2003) 1.31
Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol (2003) 1.30
Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc Natl Acad Sci U S A (2001) 1.28
The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner. EMBO J (2006) 1.27
Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology (1999) 1.25
Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpesvirus 68 reveals tissue-specific genetic requirements for latency. J Virol (2002) 1.25
Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells. J Virol (2007) 1.22
Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. Virology (2008) 1.21
Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. J Gen Virol (2005) 1.19
Effective vaccination against long-term gammaherpesvirus latency. J Virol (2003) 1.19
An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene (2007) 1.16
Role of B-cell proliferation in the establishment of gammaherpesvirus latency. J Virol (2005) 1.15
CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68. J Virol (2006) 1.11
K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis. PLoS One (2007) 1.11
Disruption of the gene encoding the gammaHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology (2003) 1.08
Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes. J Virol (2003) 1.08
Maintenance of long term gamma-herpesvirus B cell latency is dependent on CD40-mediated development of memory B cells. J Immunol (2003) 1.06
LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. Blood (2007) 1.05
Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J Virol (2008) 1.05
The M2 gene product of murine gammaherpesvirus 68 is required for efficient colonization of splenic follicles but is not necessary for expansion of latently infected germinal centre B cells. J Gen Virol (2004) 1.03
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood (2004) 1.01
A gammaherpesvirus G protein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency. J Immunol (2003) 1.00
NF-kB inhibitor blocks B cell development at two checkpoints. Med Immunol (2004) 1.00
The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium. Infect Immun (2008) 1.00
Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA. J Virol (2005) 0.99
Endothelial cells support persistent gammaherpesvirus 68 infection. PLoS Pathog (2008) 0.98
Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40. J Virol (2005) 0.96
NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major. J Immunol (2003) 0.96
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood (2005) 0.94
Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells. PLoS Pathog (2006) 0.91
Differential activation of murine herpesvirus 68- and Kaposi's sarcoma-associated herpesvirus-encoded ORF74 G protein-coupled receptors by human and murine chemokines. J Virol (2004) 0.86
NF-kappa B binds to the immunoglobulin S gamma 3 region in vivo during class switch recombination. Eur J Immunol (2006) 0.86
Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68. Virology (2006) 0.85
Cytokines and costimulatory molecules in the immune response to murine gammaherpesvirus-68. Viral Immunol (2004) 0.85
Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHVHHV-8). Cell Biochem Biophys (2004) 0.84
Accumulation of marginal zone B cells and accelerated loss of follicular dendritic cells in NF-kappaB p50-deficient mice. BMC Immunol (2005) 0.80
CD40 engagement on dendritic cells, but not on B or T cells, is required for long-term control of murine gammaherpesvirus 68. J Virol (2008) 0.79
B(1) destructive interferences and spatial phase patterns at 7 T with a head transceiver array coil. Magn Reson Med (2005) 4.01
Analysis of wave behavior in lossy dielectric samples at high field. Magn Reson Med (2002) 2.59
Exploring the limits of RF shimming for high-field MRI of the human head. Magn Reson Med (2006) 2.11
Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice. Am J Respir Crit Care Med (2007) 2.05
Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol (2003) 2.01
Identification of the in vivo role of a viral bcl-2. J Exp Med (2002) 1.88
Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu Rev Immunol (2011) 1.84
Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J Virol (2002) 1.78
Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol (2002) 1.74
The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol (2003) 1.70
Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J Virol (2003) 1.67
Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol (2006) 1.58
Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. Am J Physiol Lung Cell Mol Physiol (2005) 1.56
Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol (2002) 1.48
Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. J Virol (2005) 1.46
Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity (2002) 1.45
Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog (2007) 1.39
Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication. J Virol (2003) 1.39
Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J Clin Invest (2002) 1.34
SAR and temperature: simulations and comparison to regulatory limits for MRI. J Magn Reson Imaging (2007) 1.32
Strategies for shimming the breast. Magn Reson Med (2005) 1.32
MRI and localized proton spectroscopy in human leg muscle at 7 Tesla using longitudinal traveling waves. Magn Reson Med (2010) 1.32
Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J Virol (2009) 1.31
A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. J Exp Med (2008) 1.31
A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog (2005) 1.30
Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell (2002) 1.29
An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J Virol (2004) 1.28
Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpesvirus 68 reveals tissue-specific genetic requirements for latency. J Virol (2002) 1.25
Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog (2009) 1.23
The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells. J Virol (2005) 1.22
Effective vaccination against long-term gammaherpesvirus latency. J Virol (2003) 1.19
Polarization of the RF field in a human head at high field: a study with a quadrature surface coil at 7.0 T. Magn Reson Med (2002) 1.17
Role of B-cell proliferation in the establishment of gammaherpesvirus latency. J Virol (2005) 1.15
Experimental and numerical assessment of MRI-induced temperature change and SAR distributions in phantoms and in vivo. Magn Reson Med (2010) 1.14
Signaling through Toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo. J Virol (2008) 1.14
Identification of candidate gammaherpesvirus 68 genes required for virus replication by signature-tagged transposon mutagenesis. J Virol (2004) 1.12
A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge. J Virol (2006) 1.11
Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta. Virology (2003) 1.11
The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog (2008) 1.11
Disruption of the gene encoding the gammaHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology (2003) 1.08
Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes. J Virol (2003) 1.08
Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog (2006) 1.08
Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Virology (2002) 1.06
Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo. PLoS One (2012) 1.05
Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency. J Virol (2008) 1.05
Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J Virol (2008) 1.05
Consideration of physiological response in numerical models of temperature during MRI of the human head. J Magn Reson Imaging (2008) 1.03
Phantom design method for high-field MRI human systems. Magn Reson Med (2004) 1.01
Establishment of B-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of a DNA damage-signaling cascade. J Virol (2008) 1.01
Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection. J Virol (2006) 1.01
Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency. J Virol (2005) 1.00
Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks. Virology (2005) 0.99
ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication. J Virol (2007) 0.99
An approach to rapid calculation of temperature change in tissue using spatial filters to approximate effects of thermal conduction. IEEE Trans Biomed Eng (2013) 0.98
Measurement of SAR-induced temperature increase in a phantom and in vivo with comparison to numerical simulation. Magn Reson Med (2013) 0.98
Effect of gender on in vivo cartilage magnetic resonance imaging T2 mapping. J Magn Reson Imaging (2004) 0.97
Direct magnetic resonance imaging of histological tissue samples at 3.0T. Magn Reson Med (2007) 0.97
Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40. J Virol (2005) 0.96
An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection. J Virol (2005) 0.96
Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin. J Virol (2006) 0.96
Murine gammaherpesvirus 68 Rta-dependent activation of the gene 57 promoter. Virology (2005) 0.96
Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses. J Virol (2009) 0.95
Expansion of effector memory TCR Vbeta4+ CD8+ T cells is associated with latent infection-mediated resistance to transplantation tolerance. J Immunol (2008) 0.95
Calculation of SAR for Transmit Coil Arrays. Concepts Magn Reson Part B Magn Reson Eng (2007) 0.93
On consideration of radiated power in RF field simulations for MRI. Magn Reson Med (2012) 0.92
Murine gamma-herpesvirus immortalization of fetal liver-derived B cells requires both the viral cyclin D homolog and latency-associated nuclear antigen. PLoS Pathog (2011) 0.92
Consideration of magnetically-induced and conservative electric fields within a loaded gradient coil. Magn Reson Med (2006) 0.91
A method to separate conservative and magnetically-induced electric fields in calculations for MRI and MRS in electrically-small samples. J Magn Reson (2009) 0.90
Identification of closely spaced but distinct transcription initiation sites for the murine gammaherpesvirus 68 latency-associated M2 gene. J Virol (2008) 0.90
Rural parents' vaccination-related attitudes and intention to vaccinate middle and high school children against influenza following educational influenza vaccination intervention. Hum Vaccin (2011) 0.90
Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome. J Virol (2010) 0.89
Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo. PLoS Pathog (2012) 0.89
Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection. J Virol (2008) 0.89
Effects of end-ring/shield configuration on homogeneity and signal-to-noise ratio in a birdcage-type coil loaded with a human head. Magn Reson Med (2004) 0.88
Identification of an Rta responsive promoter involved in driving gammaHV68 v-cyclin expression during virus replication. Virology (2007) 0.88
Faraday shields within a solenoidal coil to reduce sample heating: numerical comparison of designs and experimental verification. J Magn Reson (2009) 0.88
Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis. Am J Pathol (2010) 0.88
Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines. J Virol (2004) 0.87
Reducing SAR and enhancing cerebral signal-to-noise ratio with high permittivity padding at 3 T. Magn Reson Med (2010) 0.86
Single acquisition electrical property mapping based on relative coil sensitivities: A proof-of-concept demonstration. Magn Reson Med (2014) 0.86
Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle. J Virol (2012) 0.85
The M4 gene of gammaHV68 encodes a secreted glycoprotein and is required for the efficient establishment of splenic latency. Virology (2005) 0.83
Bloch-based MRI system simulator considering realistic electromagnetic fields for calculation of signal, noise, and specific absorption rate. Magn Reson Med (2013) 0.83
The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency. J Virol (2010) 0.83
BirdcageBuilder: Design of Specified-Geometry Birdcage Coils with Desired Current Pattern and Resonant Frequency. Concepts Magn Reson (2002) 0.83
Population average T2 MRI maps reveal quantitative regional transformations in the degenerating rabbit intervertebral disc that vary by lumbar level. J Orthop Res (2014) 0.82
Numerical evaluation of image homogeneity, signal-to-noise ratio, and specific absorption rate for human brain imaging at 1.5, 3, 7, 10.5, and 14T in an 8-channel transmit/receive array. J Magn Reson Imaging (2014) 0.82
Human papillomavirus vaccination among adolescents in Georgia. Hum Vaccin Immunother (2015) 0.82
EBV framed in Burkitt lymphoma. Nat Med (2002) 0.82
Understanding reasons for participating in a school-based influenza vaccination program and decision-making dynamics among adolescents and parents. Health Educ Res (2013) 0.82
Attitudes and perceptions of private pediatricians regarding polio immunization in India. Vaccine (2011) 0.82
Tailoring the surface charge of dextran-based polymer coated SPIONs for modulated stem cell uptake and MRI contrast. Biomater Sci (2015) 0.82
Characterization of omental immune aggregates during establishment of a latent gammaherpesvirus infection. PLoS One (2012) 0.81
Complex difference constrained compressed sensing reconstruction for accelerated PRF thermometry with application to MRI-induced RF heating. Magn Reson Med (2014) 0.81
Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization. J Virol (2002) 0.81
Correlates of 2009 H1N1 influenza vaccine acceptability among parents and their adolescent children. Health Educ Res (2011) 0.81
The absence of M1 leads to increased establishment of murine gammaherpesvirus 68 latency in IgD-negative B cells. J Virol (2013) 0.80
Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection. PLoS One (2013) 0.80